CorVel Corp


CorVel Corp

  • Price (USD)137.70
  • Today's Change1.55 / 1.14%
  • Shares traded29.05k
  • 1 Year change+76.97%
  • Beta0.9942
Data delayed at least 15 minutes, as of Jul 23 2021 21:00 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

CorVel Corporation (Corvel) is a provider of workers' compensation solutions for employers, third party administrators, insurance companies and government agencies. The Company offers its services as a bundled solution, which includes claims management, as a standalone service, or as add-on services to existing customers. The Company offers its services as a bundled solution, which includes claims management, as a standalone service, or as add-on services to existing customers. The Company's network solutions include bill review, preferred provider organization (PPO) management, professional review, provider reimbursement, pharmacy services, directed care services, medicare solutions and clearinghouse services. The Company's patient management services include claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, life care planning, disability management, liability claims management and auto claims management.

  • Revenue in USD (TTM)552.64m
  • Net income in USD46.36m
  • Incorporated1991
  • Employees3.68k
  • Location
    CorVel Corp2010 Main St Ste 1020IRVINE 92614-7206United StatesUSA
  • Phone+1 (949) 851-1473
  • Fax+1 (949) 851-1469
  • Websitehttp://www.corvel.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Irhythm Technologies Inc275.94m-62.54m1.47bn1.16k--4.74--5.32-2.20-2.209.7410.570.724814.016.55238,497.80-16.43-20.56-18.98-24.4471.8573.34-22.67-25.245.54-42.040.0886--23.5948.9719.68--49.96--
Genetron Holdings Ltd - ADR67.85m-473.14m1.65bn799.00--6.66--24.29-15.39-15.391.122.78------84,914.92--------61.98---697.88--7.24-0.10380.0549--31.25---353.98------
ATI Physical Therapy Inc-100.00bn-100.00bn1.73bn0.00--0.2342----------35.60----------------------------0.00--------------
RadNet Inc.1.11bn10.98m1.83bn6.16k168.879.8516.111.650.20550.205521.393.520.6267--7.38179,567.301.481.441.991.9021.2421.052.351.67--1.240.69640.00-7.135.77-200.57---1.28--
Community Health Systems Inc11.78bn429.00m1.87bn55.00k3.89--1.720.15893.643.6498.65-12.720.75895.675.80214,127.303.47-5.054.31-6.1083.3983.344.58-6.371.390.6961.10---10.76-9.52175.7021.37-14.32--
Evolent Health Inc990.22m-270.28m1.90bn2.90k--3.02--1.92-3.16-3.1011.417.240.7185--6.73341,454.80-19.61-14.36-25.67-17.9930.9738.25-27.30-31.22---5.090.2704--20.8060.21-11.88--37.28--
Aveanna Healthcare Holdings Inc-100.00bn-100.00bn2.00bn42.00k--5.62----------1.93----------------------------0.8111--8.02--25.44------
InnovAge Holding Corp618.68m-38.36m2.32bn1.91k--7.08--3.75-0.2958-0.29584.752.42------323,914.70--------27.72---6.32----0.3410.1914--21.81--34.22------
Magellan Health Inc4.62bn33.63m2.47bn9.00k72.781.2917.050.5361.3015.24179.1873.091.43100.515.32512,977.901.041.531.422.253.424.010.72830.8742.992.440.21680.000.261-0.0866-67.88-33.631.07--
CorVel Corporation552.64m46.36m2.48bn3.68k53.9811.1735.484.482.552.5530.4212.331.31--8.47150,134.2011.0212.8917.0220.0722.3720.818.397.17----0.00---6.681.88-2.1610.200.5746--
MEDNAX Inc1.74bn14.27m2.48bn5.60k167.753.2356.391.420.1713-9.1020.668.890.5114--4.81310,617.700.41933.110.46543.44----0.826.72--2.380.5658---2.57-9.01-122.70--1.24--
Veracyte Inc123.06m-65.06m2.64bn320.00--2.71--21.45-1.09-1.092.1714.490.19056.715.24384,575.00-10.07-15.78-10.49-17.2166.1864.72-52.87-28.4610.88-147.590.0009---2.4018.87-177.08---14.38--
Burning Rock Biotech Ltd(ADR)72.40m-87.10m2.78bn938.00--7.74--38.41-0.8408-0.84080.69983.440.25011.564.7877,183.38-28.05---31.56--73.76---112.12--8.41-990.430.0183--12.64---41.22------
Agape ATP Corp3.75m252.87k2.82bn35.00----8,569.75752.020.00070.00070.010.01480.6959--14.35107,268.604.69--5.17--77.27--6.74--4.99--0.00--------------
Accolade Inc193.99m-85.40m3.23bn1.72k--6.58--16.67-1.81-1.814.617.430.3834--18.28112,785.50-16.88---22.21--44.65---44.02-----4.680.39--28.57--1.39------
Surgery Partners Inc1.93bn-149.90m3.37bn10.80k--10.0328.311.75-3.00-3.0038.3612.960.3627.295.69178,842.600.38210.63090.5350.887425.7528.201.061.621.671.120.606--1.5714.15-40.81--5.11--
Data as of Jul 23 2021. Currency figures normalised to CorVel Corp's reporting currency: US Dollar USD

Institutional shareholders

41.11%Per cent of shares held by top holders
HolderShares% Held
Kayne Anderson Rudnick Investment Management LLCas of 30 Jun 20211.85m10.29%
BlackRock Fund Advisorsas of 31 Mar 20211.40m7.80%
The Vanguard Group, Inc.as of 31 Mar 20211.01m5.63%
Renaissance Technologies LLCas of 31 Mar 20211.00m5.58%
Dimensional Fund Advisors LPas of 31 Mar 2021647.96k3.60%
T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 2021356.75k1.98%
Boston Trust Walden, Inc.as of 31 Mar 2021344.17k1.91%
SSgA Funds Management, Inc.as of 31 Mar 2021300.12k1.67%
Norges Bank Investment Managementas of 31 Dec 2020269.63k1.50%
Geode Capital Management LLCas of 31 Mar 2021206.68k1.15%
More ▼
Data from 31 Dec 2020 - 30 Jun 2021Source: FactSet Research Systems Inc.
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.